BlackRock’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-385,474
| Closed | -$432K | – | 5520 |
|
|
2025
Q2 | $432K | Sell |
385,474
-645,050
| -63% | -$788K | ﹤0.01% | 4483 |
|
|
2025
Q1 | $1.19M | Sell |
1,030,524
-23,504
| -2% | -$43.7K | ﹤0.01% | 4146 |
|
|
2024
Q4 | $6.44M | Buy |
1,054,028
+154,107
| +17% | +$1.83M | ﹤0.01% | 3622 |
|
|
2024
Q3 | $14.9M | Buy |
899,921
+16,840
| +2% | +$184K | ﹤0.01% | 3211 |
|
|
2024
Q2 | $6.07M | Buy |
883,081
+125,118
| +17% | +$1.07M | ﹤0.01% | 3622 |
|
|
2024
Q1 | $7.31M | Sell |
757,963
-4,507
| -0.6% | -$52.2K | ﹤0.01% | 3516 |
|
|
2023
Q4 | $6.34M | Sell |
762,470
-108,446
| -12% | -$630K | ﹤0.01% | 3595 |
|
|
2023
Q3 | $7.27M | Buy |
870,916
+13,745
| +2% | +$117K | ﹤0.01% | 3503 |
|
|
2023
Q2 | $7.91M | Buy |
857,171
+86,575
| +11% | +$970K | ﹤0.01% | 3523 |
|
|
2023
Q1 | $10.6M | Sell |
770,596
-18,639
| -2% | -$386K | ﹤0.01% | 3291 |
|
|
2022
Q4 | $13.4M | Buy |
789,235
+49,303
| +7% | +$986K | ﹤0.01% | 3246 |
|
|
2022
Q3 | $16.8M | Buy |
739,932
+16,222
| +2% | +$328K | ﹤0.01% | 3131 |
|
|
2022
Q2 | $13M | Buy |
723,710
+28,886
| +4% | +$515K | ﹤0.01% | 3354 |
|
|
2022
Q1 | $18.6M | Buy |
694,824
+17,867
| +3% | +$333K | ﹤0.01% | 3217 |
|
|
2021
Q4 | $19.9M | Buy |
676,957
+36,220
| +6% | +$1.8M | ﹤0.01% | 3279 |
|
|
2021
Q3 | $42.1M | Buy |
640,737
+7,936
| +1% | +$607K | ﹤0.01% | 2770 |
|
|
2021
Q2 | $52.6M | Sell |
632,801
-106,244
| -14% | -$7.87M | ﹤0.01% | 2666 |
|
|
2021
Q1 | $56.7M | Buy |
739,045
+17,691
| +2% | +$1.61M | ﹤0.01% | 2536 |
|
|
2020
Q4 | $63.7M | Buy |
721,354
+265,714
| +58% | +$18.7M | ﹤0.01% | 2333 |
|
|
2020
Q3 | $33.6M | Sell |
455,640
-99,847
| -18% | -$5.91M | ﹤0.01% | 2526 |
|
|
2020
Q2 | $40.5M | Buy |
555,487
+108,847
| +24% | +$6.61M | ﹤0.01% | 2382 |
|
|
2020
Q1 | $25.1M | Buy |
446,640
+113,561
| +34% | +$4.98M | ﹤0.01% | 2485 |
|
|
2019
Q4 | $12.7M | Buy |
333,079
+245,464
| +280% | +$6.17M | ﹤0.01% | 3126 |
|
|
2019
Q3 | $1.55M | Buy |
+87,615
| New | +$1.77M | ﹤0.01% | 3831 |
|
Other funds holding IGMS
BlackRock's IGMS Position: Q3 2025 in Review
BlackRock sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 385,474 shares — an estimated $432K sold.
BlackRock first reported a position in IGMS in Q3 2019 and held it in 24 quarters. The position peaked at $63.7M in Q4 2020. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- BlackRock reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- BlackRock sold 385,474 IGM Biosciences shares in Q3 2025, an estimated $432K.
- BlackRock first reported a position in IGM Biosciences in Q3 2019 and held it in 24 quarters.
- BlackRock's IGM Biosciences position peaked at $63.7M in Q4 2020.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on BlackRock's 13F filing for Q3 2025, filed 12 Nov 2025.